Immune factors in breast milk related to infant milk allergy are independent of maternal atopy - 11/05/15
Doi : 10.1016/j.jaci.2014.10.051
Kirsi M. Järvinen, MD, PhD a, b, ∗ 
, Mayte Suárez-Fariñas, PhD c, Erkki Savilahti, MD, PhD d, Hugh A. Sampson, MD b, M. Cecilia Berin, PhD b
, Mayte Suárez-Fariñas, PhD c, Erkki Savilahti, MD, PhD d, Hugh A. Sampson, MD b, M. Cecilia Berin, PhD b a Division of Allergy and Immunology and Center for Immunology and Microbial Diseases, Albany Medical College, Albany, NY
b Division of Pediatric Allergy and Immunology and Jaffe Institute for Food Allergy, Icahn School of Medicine at Mt Sinai, New York, NY
c Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
d Division of Paediatric Gastroenterology and Clinical Immunology, Children's Hospital, University of Helsinki, Helsinki, Finland
| The project described was supported by grant no. K08 AI091655 (to K.M.J.) from the National Institute of Allergy and Infectious Diseases. H.A.S. is supported in part by grants from the National Institutes of Health (NIH; RR026134, AI44236, and AI066738). C.B. is supported in part by NIH grant AI093577. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the NIH. |
|
| Disclosure of potential conflict of interest: This study was funded by the National Institutes of Health and the National Institute of Allergic and Infectious Diseases. K. M. Järvinen has received consultancy fees from Merck and DBV Technologies, and receives royalties from UpToDate. M. Suárez-Fariñas has received compensation from Albany Medical College for various review activities, as well as consultancy fees from Regeneron, Dermira, and Mount Sinai St Luke's; she has received payment for delivering lectures from Pfizer. H. A. Sampson's institution has received funding from Food Allergy Research and Education (FARE); he has received consultancy fees from Allertein Therapeutics, Regeneron, and the Danone Institute, as well as payment for delivering lectures from Thermo Fisher Scientific, UCB, and Pfizer. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 135 - N° 5
P. 1390 - mai 2015 Retour au numéro
Article précédent
- Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency
- Markus G. Seidel, Tatjana Hirschmugl, Laura Gamez-Diaz, Wolfgang Schwinger, Nina Serwas, Andrea Deutschmann, Gregor Gorkiewicz, Werner Zenz, Christian Windpassinger, Bodo Grimbacher, Christian Urban, Kaan Boztug
- Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-?R1 or IFN-?R2 deficiency
- Francesca Conti, Walmir Cutrim Aragão Filho, Carolina Prando, Caroline Deswarte, Marjorie Hubeau, Peter E. Newburger, Jean-Laurent Casanova, Jacinta Bustamante, Antonio Condino-Neto
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?